C
Christoph Rischpler
Researcher at University of Duisburg-Essen
Publications - 201
Citations - 4022
Christoph Rischpler is an academic researcher from University of Duisburg-Essen. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 27, co-authored 150 publications receiving 2539 citations. Previous affiliations of Christoph Rischpler include Ludwig Maximilian University of Munich & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Wolfgang P. Fendler,Wolfgang P. Fendler,Jeremie Calais,Matthias Eiber,Matthias Eiber,Robert R. Flavell,Ashley Mishoe,Felix Y. Feng,Hao G. Nguyen,Robert E. Reiter,Matthew Rettig,Shozo Okamoto,Louise Emmett,Helle D Zacho,Harun Ilhan,Axel Wetter,Christoph Rischpler,Heiko Schöder,Irene A. Burger,Jeannine Gartmann,Raven Smith,Eric J. Small,Roger Slavik,Peter R. Carroll,Ken Herrmann,Ken Herrmann,Johannes Czernin,Thomas A. Hope +27 more
TL;DR: Using blinded reads and independent lesion validation, this single-arm prospective trial establishes high PPV for 68Ga-PSMA-11 PET, detection rate and interreader agreement for localization of recurrent prostate cancer.
Journal ArticleDOI
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.
Jeremie Calais,Francesco Ceci,Francesco Ceci,Matthias Eiber,Matthias Eiber,Thomas A. Hope,Michael S Hofman,Christoph Rischpler,Tore Bach-Gansmo,Cristina Nanni,Bital Savir-Baruch,David Elashoff,Tristan Grogan,Magnus Dahlbom,Roger Slavik,Jeannine Gartmann,Kathleen Nguyen,Vincent Lok,Hossein Jadvar,Amar U. Kishan,Matthew Rettig,Robert E. Reiter,Wolfgang P. Fendler,Wolfgang P. Fendler,Johannes Czernin +24 more
TL;DR: Comparing prospectively paired 18F-fluciclovine and PSMA PET-CT scans for localising biochemical recurrence of prostate cancer after radical prostatectomy in patients with low prostate-specific antigen (PSA) concentrations found PSMA should be the PET tracer of choice when PET- CT imaging is considered for subsequent treatment management decisions.
Journal ArticleDOI
Hybrid PET/MR Imaging of the Heart: Potential, Initial Experiences, and Future Prospects
TL;DR: A comparative summary of the existing applications for PET and MR in the field of cardiology is presented and potential cardiac applications exploiting unique properties of the newly introduced combined instrumentation are suggested.
Journal ArticleDOI
Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen–ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy
Isabel Rauscher,Charlotte Düwel,Bernhard Haller,Christoph Rischpler,Matthias Heck,Jürgen E. Gschwend,Markus Schwaiger,Tobias Maurer,Matthias Eiber,Matthias Eiber +9 more
TL;DR: It seems reasonable to perform 68Ga-PSMA-ligand PET/CT also in patients with early biochemical recurrence, as it can tailor further therapy decisions (eg, local vs systemic treatment) and the established prediction nomograms can further assist urologists in discussions on the use of 68Ga/CT with their patients in specific clinical settings.
Journal ArticleDOI
68Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: an international multicenter prospective study
Wolfgang P. Fendler,Jeremie Calais,Martin Allen-Auerbach,Christina Bluemel,Nina Eberhardt,Louise Emmett,Pawan Gupta,Markus Hartenbach,Thomas A. Hope,Shozo Okamoto,Christian H. Pfob,Thorsten Pöppel,Christoph Rischpler,Sarah M. Schwarzenböck,Vanessa Stebner,Marcus Unterrainer,Helle D Zacho,Tobias Maurer,Christian Gratzke,Alexander Crispin,Johannes Czernin,Ken Herrmann,Matthias Eiber +22 more
TL;DR: The interpretation of 68Ga-PSMA-11 PET/CT for prostate cancer staging is highly consistent among observers with high levels of experience, especially for nodal and bone assessments.